2018 Investment Forum

Wednesday, November 14, 2018
9:00 a.m.to 1:00 p.m.
The University Club of Chicago

At Altair’s 2018 Investment Forum, Dr. Rex Chisholm discussed the approaches and benefits of genomics informed personalized medicine, or precision medicine. Trade and policy expert, Phil Levy, then gave an update on policymaking and the global economy following the midterm election, and Altair’s Chairman, CIO and Director of Investment Research gave an update on investment trends and economic developments affecting markets currently and as we head into 2019. Click the “Watch the Presentation” button to see the on-demand webinars available for all presentations.

Precision Medicine: How Far Have We Come and Where Are We Headed?

Our Director of Communications, Anna Nichols interviews Dr. Rex L. Chisholm, Ph.D., Vice Dean for Scientific Affairs and Graduate Education; Adam and Richard T. Lind Professor of Medical Genetics, Center for Genetic Medicine, Dept.of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University


Policymaking and the Global Economy*

Phil I. Levy, Senior Fellow, Global Economy, Chicago Council on Global Affairs; Adjunct Professor of Strategy, Northwestern University Kellogg School of Management


Investment Trends and Economic Developments Affecting Markets*

Steve Weinstein, Altair’s Chairman, Jason Laurie, Managing Director and Chief Investment Officer, and David Lin, Director of Investment Research


*Due to confidential material, you will need a password to access this presentation. Please contact us at marketing@altairadvisers.com for access.